Frontlight ResearchEarly access
Trial site
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Obesity2 trials
- Asthma1 trial
- Crohn's disease1 trial
- Lupus (SLE)1 trial
- Rheumatoid arthritis1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Amgen1 trial
Running trials
Recruiting
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Asthma1 recruiting
- Crohn's disease1 recruiting
- Lupus (SLE)1 recruiting
- Rheumatoid arthritis1 recruiting
- Ulcerative colitis1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026